Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha

Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha

Item

http://www.wikidata.org/entity/Q35606708

Q35606708

about

Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer Epidermal growth factor mediates detachment from and invasion through collagen I and Matrigel in Capan-1 pancreatic cancer cells Apoptosis: targets in pancreatic cancer Pathways for aberrant angiogenesis in pancreatic cancer Effects of STI571 (gleevec) on pancreatic cancer cell growth Immunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent Cancers The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer Influences of the lysosomal associated membrane proteins (Lamp-1, Lamp-2) and Mac-2 binding protein (Mac-2-BP) on the prognosis of pancreatic carcinoma Overexpression of activin A in stage IV colorectal cancer Enhanced fibroblast growth factor 5 expression in stromal and exocrine elements of the pancreas in chronic pancreatitis Bioorthogonal labeling cell-surface proteins expressed in pancreatic cancer cells to identify potential diagnostic/therapeutic biomarkers Identification and characterization of endonuclein binding proteins: evidence of modulatory effects on signal transduction and chaperone activity Increased expression of transforming growth factor beta s after acute oedematous pancreatitis in rats suggests a role in pancreatic repair.Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer.Expression of vascular endothelial growth factors A and C in human pancreatic cancer.Novel recombinant immunotoxin of EGFR specific nanobody fused with cucurmosin, construction and antitumor efficiency in vitro.Biological approaches to therapy of pancreatic cancer.Pancreatic cancer: molecular pathogenesis and new therapeutic targets.Pancreatic gastrin stimulates islet differentiation of transforming growth factor alpha-induced ductular precursor cells.Adult pancreatic acinar cells give rise to ducts but not endocrine cells in response to growth factor signaling.Potato carboxypeptidase inhibitor, a T-knot protein, is an epidermal growth factor antagonist that inhibits tumor cell growth.DeltaNp63alpha-mediated induction of epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistance Chemoprevention strategies for pancreatic cancer Endonuclein is a cell cycle regulated WD-repeat protein that is up-regulated in adenocarcinoma of the pancreas.Growth factors and their receptors in pancreatic cancer.EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer.Gene therapy in pancreatic cancer.Concomitant targeting of EGF receptor, TGF-beta and SRC points to a novel therapeutic approach in pancreatic cancer.microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions.Chronic pancreatitis is associated with increased concentrations of epidermal growth factor receptor, transforming growth factor alpha, and phospholipase C gamma.A tolerability and pharmacokinetic study of adjuvant erlotinib and capecitabine with concurrent radiation in resected pancreatic cancer Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines.Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.Biology and management of pancreatic cancer.The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-KrasG12D/+ transgenic mouse model.Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growth Oncogenic K-Ras and loss of Smad4 mediate invasion by activating an EGFR/NF-κB Axis that induces expression of MMP9 and uPA in human pancreas progenitor cells.Developments in the systemic therapy of pancreatic cancer.Systemic therapy for advanced pancreatic cancer.

P2860

Q21245763-DC59742A-3DEB-456C-9A56-6BA29064AA3E Q24564355-AF2D06F4-BE3F-4616-A9EC-1392A1EAC3BA Q24792963-A40EC999-30B6-4C5F-B0BA-72C225D4739F Q24800170-E8287156-24CA-47F9-8F09-138E97BE776C Q24800215-7978E71F-CE78-4FB1-8399-7FDC68398D09 Q24802841-F67D826D-1806-4258-943F-3B04FACDFBD0 Q26751473-6DCE9B50-EBAC-4C2A-95D5-529D04B96116 Q28145081-DF0F6540-951E-48D8-AA65-8C66A9884F57 Q28216866-D8ACDC6A-7A43-4CBD-B002-A77FD345D1BD Q28346273-3B867B8C-124E-40F8-97B4-273E3664BD13 Q28369085-F5CCF7F6-C1ED-4274-B2E9-7F22EFE09531 Q28834154-B5D0C366-31CA-447A-9FDA-75F8EF103F55 Q33520350-7651F892-44AF-441E-B6C4-2D458ECC2CA7 Q33617690-A7CA36A7-FF62-4157-9E67-57CD380C2B93 Q33684453-3FA8EE12-9E6C-4381-AE21-D689D4F041AC Q33788147-C1B51295-390E-45B4-A1B2-C80BBE89A922 Q33888876-BFC25FB8-70FE-4D19-9831-CFFD49AE98C4 Q33899938-36873801-9FD1-4EDC-B0F7-E3A9F38A5CEA Q33899954-3F3D4375-2CA9-4F00-BA77-A1216D80A529 Q33902109-C4AC3BBF-60C2-44B8-90A3-0641B927E414 Q33929630-B7CF09CD-6B32-4F0B-B609-18EE261EFB1E Q34066456-8CD6E879-C1C9-41C4-B356-34CD3319876D Q34067050-29DA5F07-B27F-427F-977C-BA93DF64EEF6 Q34082960-CF06E4CF-3B72-422D-9722-498DCC47688D Q34114668-81263FFE-98A5-423C-80C7-CA66C88871E1 Q34116893-DD83D719-CF90-487E-8BEF-4400AFD7D67C Q34163334-20C50BD8-4195-4E25-B6B3-C5F518A8C665 Q34302954-9D221366-D453-4295-8373-D0BF0C2D3F6F Q34326442-25CB0399-3486-4556-841E-90B71043820A Q34375528-F604DEED-F032-43E2-8EE2-2733955B2569 Q34379846-1D944FD0-3AEA-47C5-AE03-77E22A2D7BE8 Q34398312-8D15A5AF-F4B5-41E3-A3E9-3BD171AFDF03 Q34496697-C57CCA80-9932-44A9-8123-FD6A17498AB1 Q34642090-0C6D6CBF-D0E9-44F6-9F7D-E443B92CE48A Q34649019-BE340D49-007D-4176-B9BC-589359795956 Q34681112-E6AB9379-43C5-43D1-8F36-88CA5F30B0F3 Q34812100-77BA435B-4EA5-4D85-8105-A9FBD6A4FC55 Q35067751-84B2D70E-531D-41F5-848F-6D9C7B877C5F Q35087326-D59CA3D9-11E9-4D25-A017-52D93D7A4C2F Q35089138-82F683D5-3A3C-4504-9078-625B73727520

P2860

Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha

Item

http://www.wikidata.org/entity/Q35606708

description

1992 nî lūn-bûn

@nan

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

1992年论文

@zh

1992年论文

@zh-cn

name

Overexpression of the epiderma ...... ansforming growth factor alpha

@ast

Overexpression of the epiderma ...... ansforming growth factor alpha

@en

type

Item

label

Overexpression of the epiderma ...... ansforming growth factor alpha

@ast

Overexpression of the epiderma ...... ansforming growth factor alpha

@en

prefLabel

Overexpression of the epiderma ...... ansforming growth factor alpha

@ast

Overexpression of the epiderma ...... ansforming growth factor alpha

@en

P1476

Overexpression of the epiderma ...... ansforming growth factor alpha

@en

P2093

B Chandrasekar

http://www.w3.org/2001/XMLSchema#string

H Friess

http://www.w3.org/2001/XMLSchema#string

H G Beger

http://www.w3.org/2001/XMLSchema#string

M Buchier

http://www.w3.org/2001/XMLSchema#string

M Korc

http://www.w3.org/2001/XMLSchema#string

Y Yamanaka

http://www.w3.org/2001/XMLSchema#string

P2860

Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity

Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter

Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa

Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle

Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization

Transformation of normal rat kidney (NRK) cells by an infectious retrovirus carrying a synthetic rat type alpha transforming growth factor gene.

RFLPs for epidermal growth factor (EGF), a single copy sequence at 4q25-4q27

P304

1352-1360

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI116001

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1992-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1401070

http://www.w3.org/2001/XMLSchema#string

P921

overexpression

P932

443180

http://www.w3.org/2001/XMLSchema#string

Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha

about

P2860

P2860

Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932